About Compare GLP-1
Neutral. Data-driven. No pay-for-play.
Why We Built This
The GLP-1 telehealth market exploded from a handful of providers to more than 20 in under two years. Pricing structures vary wildly, medication formats differ, and marketing claims are often misleading. We built Compare GLP-1 because consumers deserve a single place where every provider is evaluated on the same criteria — without any provider paying to be ranked higher.
No provider has ever paid for placement, priority ranking, or editorial coverage on Compare GLP-1. Our revenue comes from affiliate commissions earned when visitors click through to a provider. This model lets us stay free for readers while maintaining editorial independence.
What We Do
We research, compare, and publish pricing and service data for telehealth providers offering semaglutide and tirzepatide. Our work includes side-by-side provider comparison tables, a guided quiz to match visitors with appropriate providers, head-to-head verdict articles, and a published methodology explaining exactly how we evaluate each service.
Our Editorial Standards
Every provider listed on Compare GLP-1 is evaluated against the same criteria: pricing transparency, medication formats offered, consultation model, prescribing clinician credentials, pharmacy accreditation, and user experience. We do not accept payment for reviews, and providers cannot preview or edit content before publication.
We clearly label sponsored or affiliate links throughout the site. When pricing data cannot be independently verified, we note it. When a provider changes its offering, we update our comparison within one editorial cycle (typically within 30 days).
How We Earn Revenue
Compare GLP-1 earns affiliate commissions when visitors click through to a provider and complete an action (such as starting a consultation). This is a standard internet publishing model and does not affect how we rank, review, or present any provider.
- Affiliate relationships are disclosed on every page with provider links
- Commission rates do not influence ranking position
- Providers with no affiliate relationship are still included when they meet our evaluation criteria
- Our full methodology is published and publicly available
Who Publishes This Site
Compare GLP-1 is published by Scout Theory LLC, an independent digital publishing company. Scout Theory operates a network of consumer health and comparison resources. We are not a healthcare provider, pharmacy, or medical practice. We do not prescribe medications, diagnose conditions, or provide medical advice.
Important Limitations
We are a consumer information resource, not a medical authority. While we strive for accuracy, telehealth pricing, availability, and medication options change frequently. Always verify current pricing and availability directly with any provider before starting treatment. Compounded GLP-1 medications are not FDA-approved.